Gluco-Chaser™ Inc. Announces Disposable Glucose Sensor Results with Non-Enzymatic Electrochemistry
Gluco-ChaserTM Inc. is pleased to announce that its disposable strip BGM (blood glucose monitoring) prototype sensor with non-enzymatic electrochemistry achieved a 5-second glucose reading from human whole blood (Applied Materials Today, 10, 24, March 2018, “Disposable Non-enzymatic Blood Glucose Sensing Strip Based on Nanoporous Platinum Particles” https://www.sciencedirect.com/science/article/pii/S2352940717302445). It does not compromise the accuracy of Gluco-Chaser’s proprietary nanoporous sensor technology (Error Grid Analysis A+B 98%; N=100). This also shows the possibility of delivering strong commercial impact for glucose monitoring in general, as a strong indicator of success for Gluco-Chaser’s CGM (continuous glucose monitoring) working calibration-free for 5 days in animal tests.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180208005529/en/
Gluco-Chaser’s proprietary non-enzymatic electrochemical sensor for Blood Glucose Monitoring (left) and Error Grid Analysis Results using the sensor (cited from Applied Materials Today 10, 24, March 2018) (Graphic: Business Wire)
Last November, Gluco-Chaser reported its working prototype of the CGM sensor (https://www.businesswire.com/news/home/20171121005451/en/Gluco-Chaser-Releases-Working-Prototype-Proprietary-Non-Enzymatic-Electrochemical). With the features of high throughput production of non-enzymatic nanoporous layers, Gluco-Chaser is expected to offer highly competitive pricing for both CGM and BGM . Moreover, its CGM sensors accomplished conditioning within 30 minutes , which is unprecedented.
Gluco-Chaser has been working with Knobbe Martens , a leading IP law firm (Irvine, CA). In 2017, the company filed two US provisional patent applications and five US non-provisional patent applications. Gluco-Chaser plans to file additional US patent applications and also pursue international protection for its inventions. Here is a list of the company’s non-provisional patent applications:
|15/844,479||Glucose Sensing System and Method|
|15/844,484||Method of Making Colloid and Nanoporous Layer|
|15/844,507||Non-Enzymatic Glucose-Sensing Device with Nanoporous Structure and Conditioning of the Nanoporous Structure|
|15/845,668||Glucose Sensor Apparatus Addressing Interference and Ascorbic Acid and Acetaminophen|
|15/844,515||Glucose Sensor Device with Maltose Blocking Layer|
These are intended to renew and upgrade the existing patents, describing the underlying sciences and its relevant manufacture processing techniques. They include (1) manufacture-compatible, high throughput method to prepare nanoporous platinum (US 15/844,484); (2) unprecedented 30-minute conditioning of a CGM (Continuous Glucose Monitoring) sensor built with the non-enzymatic nanoporous platinum electrode (US 15/844,507); and (3) calibration-free testing of an animal subject (US 15/844,479; US 15/844,484; US 15/844,507).
About Gluco-Chaser Gluco-Chaser is a DBA of UXN Inc., a Delaware company (Redmond, WA), as a wholly-owned subsidiary of UXN Co., Ltd. (South Korea). Shaping the future of the glucose monitoring industry has been at the forefront of the company’s missions. True to its mission, the company has optimized the relevant technologies for over a decade.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)21.9.2018 22:13 | Pressemelding
Glorious beaches by day and theme park fireworks by night just got more convenient for Philadelphia travelers. American Airlines announced today that it will begin nonstop flights to Orlando Melbourne International Airport (MLB) starting February 16, 2019. The Central Florida airport is conveniently located in the heart of the tourism region and is the closest airport to NASA rocket launches, Port Canaveral’s cruises and what critics call “some of the most beautiful beaches Florida has to offer.” The flights will depart Saturdays from Philadelphia at 8:05 a.m., arriving in Florida at 10:48 a.m. The Embraer 175 jet arrival time syncs perfectly with cruise ship noon early boarding. Melbourne Airport Express offers nonstop shuttle service to the port, and all major rental car companies are onsite. The return flight to PHL departs at 11:24 a.m. and arrives in PHL at 1:55 p.m., with enough time to connect to some of American’s largest international destinations, including recently announced
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice21.9.2018 17:43 | Pressemelding
BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Amy Palladino has joined the agency as Executive Vice President, Managing Director in the agency’s U.S. Corporate Practice. Based in New York, Palladino will focus on senior client counsel and executive positioning for the agency’s largest corporate clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005507/en/ Amy Palladino Joins BCW (Burson Cohn & Wolfe) “Amy is a talented and highly experienced communications executive with a track record of solving clients’ complex challenges and building business through smart, integrated communications approaches,” said Chris Foster, President, North America, BCW. “Her creativity and judgement will be enormously valuable to our current and prospective clients.” Palladino has more than 20 years of experience advising global clients across numerous industries, including technology, healthcar
Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 16:41 | Pressemelding
Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo
Florian Winterstein Becomes New CEO of Jedox21.9.2018 15:46 | Pressemelding
The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16 | Pressemelding
HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati